Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.
Yesterday Bill Gates released his annual letter, highlighting the philanthropic work of the Bill & Melinda Gates Organization and announcing his expectations for continued improvements in global health, agricultural research and U.S. education in the next year. Throughout the letter, Gates reiterated that innovation was the key to achieving their goals of improving the lives of people around the world.